bioMerieux Recalls mini VIDAS Systems Due to Performance Issues
bioMerieux is recalling 1,866 mini VIDAS systems because pump clogging and label displacement may cause erroneous test results.
The agency’s classification
FDA (Devices): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 2/5 (Moderate).
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II, and the source text describes performance issues leading to erroneous results without reporting specific injuries, illnesses, or hospitalizations, fitting the criteria for a moderate severity score.
Plain-English summary
bioMerieux, Inc. is recalling 1,866 units of the mini VIDAS System in combination with Quality Control VIDAS (QCV). The recall covers various models of the mini VIDAS analyzer distributed worldwide, including nationwide distribution across the United States and in numerous international countries.
The recall is due to an increase in events affecting performance, specifically pump clogging and the displacement of the color-coded SPR label (DOT). These performance issues could contribute to erroneous results for any assay performed on the VIDAS and mini VIDAS system due to a decrease of pipetted volume.
The mini VIDAS system is an immunodiagnostic system intended to be used by trained and qualified laboratory professionals for in vitro diagnostic (IVD) purposes, veterinary, and industrial applications. The Quality Control VIDAS (QCV) is an automated test used to detect abnormal operation of the instrument's pipette mechanisms and optical systems.
The recalled product
- Product
- BioMerieux mini VIDAS System in combination with Quality Control VIDAS* (QCV*) Product Usage: the Quality Control VIDAS (QCV) is an automated test for use on the VIDAS¿ system to detect abnormal operation of the VIDAS and mini VIDAS instrument pipette mechanisms and optical…
- Manufacturer
- bioMerieux, Inc.
- Affected units
- 1,866
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (18)
- Description
- Reference No. (UDI No.): MINI VIDAS ANALYSER EU
- 99174 (03573026111021)
- MINI VIDAS ANALYSER US
- 99175 (03573026111045)
- MINI VIDAS 100-120 VOLT VDE/CE
- 99733 (03573026118662)
- MINI VIDAS 200-240 VOLT VDE/CE
- 99734 (03573026118655)
- MINI VIDAS BLUE 110 / 220 V
- 99737 (03573026140441)
- MINI VIDAS ARKRAY ANALYZER
- 99739 (03573026140465)
- MINI VIDAS
- 410416 (03573026351656)
- W1421 (03573026029180)
- MINIVIDAS INDUSTRY US
- 421001 (03573026553319)
Distribution
Part of a larger recall action
This product is one of 2 recalled by bioMerieux, Inc. under a single FDA (Devices) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 2 products in this recall →Related recalls
Same manufacturer · bioMerieux, Inc.
See all →- HighBiomerieux VITEK 2 AST-N461 Test Kit Recalled for Card Pouch Damage
FDA (Devices) · 2026-09-30
- HighVITEK 2 AST-N447 Test Kit Potentially Returns False Resistant Results
FDA (Devices) · 2026-07-15
- HighSusceptibility test cards recalled over false resistant antibiotic results
FDA (Devices) · 2026-02-11
- HighAntimicrobial susceptibility test cards recalled over false colistin resistance results
FDA (Devices) · 2025-10-08
- SevereVITEK 2 AST Test Kits: Ceftriaxone Concentration Error Risk
FDA (Devices) · 2024-05-01
Same hazard · erroneous results
See all →- HighBeckman Coulter DxC 500i Analyzer Modules Recalled for Software Defect
FDA (Devices) · 2026-08-26
- HighChemistry analyzer control modules recalled over software that may give erroneous results
FDA (Devices) · 2025-12-24
- HighLaboratory automation recalled over unlabelled or mismatched secondary sample tubes
FDA (Devices) · 2025-12-03
- HighBlood lead test kits recalled over mislabeled calibration buttons
FDA (Devices) · 2025-12-03
- HighLaboratory automation recalled over sample tubes with mismatched labels
FDA (Devices) · 2025-12-03
Similar recalls
- ModerateVIDAS Quality Control Product Recalled for Storage Condition Deviation
FDA (Devices) · 2023-01-11
- ModeratebioMerieux Recalls VIDAS LH Test Kits Due to Calibration Issues
FDA (Devices) · 2018-08-08
- ModerateBioMerieux Recalls VIDAS FSH Assay Kits Due to Calibration Issues
FDA (Devices) · 2018-07-04
- ModerateBiomerieux Recalls VIDAS CMV IgM Tests Due to Calibration Issues
FDA (Devices) · 2021-04-21
- ModeratebioMerieux Recalls VIDAS Testosterone Assay Due to Overestimated Results
FDA (Devices) · 2017-07-19
- HighBiomerieux VIDAS 3 Immunoanalyzer Recalled for False Results Due to Software Error
FDA (Devices) · 2020-02-12